ConductScience.org, home

Trial · NCT02334384

Safety and Tolerability Study of Antimicrobial TheraGauze for Skin Abscess

NCT02334384, Phase 1, Phase 2, Completed, Eastern Virginia Medical School; results first posted 2018-08-29

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Safety and Tolerability Study of Antimicrobial TheraGauze for Skin Abscess. Trials, record NCT02334384. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02334384

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Safety and Tolerability Study of Antimicrobial TheraGauze for Skin Abscess
NCT number
NCT02334384
Status
Completed
Phases
Phase 1, Phase 2
Enrollment
6 participants, actual
Lead sponsor
Eastern Virginia Medical School
Conditions
Furunculosis
Interventions
Antimicrobial TheraGauze
First posted
2015-01-08
Last updated
2018-10-04
Results first posted
2018-08-29

Source ClinicalTrials.gov

Registered outcomes1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumber of Side-effects1 week
Evaluate for evidence of side-effects from Antimicrobial TheraGauze packing of skin abscess wounds compared with standard of care (i.e. cotton wick or iodoform wick). Tests for statistical significance will be made for multiple potential side-effects including: 1) erythema around the wound packing, 2) increased pain at the wound site, 3) increased tenderness around the wound 4) increased discharge from the wound, 4) new rash, and 5) fever.

Outcomes1

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Side-effects1 weekParticipantsCOUNT_OF_PARTICIPANTS

Results by group2

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Side-effectsAntimicrobial TheraGauze4Participants
Number of Side-effectsStandard Wound Packing2Participants

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDAntimicrobial TheraGauze4
Overall StudySTARTEDStandard Wound Packing2
Overall StudyCOMPLETEDAntimicrobial TheraGauze3
Overall StudyCOMPLETEDStandard Wound Packing1
Overall StudyNOT COMPLETEDAntimicrobial TheraGauze1
Overall StudyNOT COMPLETEDStandard Wound Packing1

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityAntimicrobial TheraGauze04
Total, all-cause mortalityStandard Wound Packing02
Total, other adverse eventsAntimicrobial TheraGauze04
Total, other adverse eventsStandard Wound Packing02
Total, serious adverse eventsAntimicrobial TheraGauze04
Total, serious adverse eventsStandard Wound Packing02

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons3

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Antimicrobial TheraGauze vs Standard Wound Packing: Number of Side-effectsTrial comparisons
Antimicrobial TheraGauze vs Standard Wound Packing: deaths from any causeTrial comparisons
Antimicrobial TheraGauze vs Standard Wound Packing: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02334384

GET https://conductscience.org/api/trials/v1/NCT02334384/registered